
Oncology NEWS International
- Oncology NEWS International Vol 19 No 4
- Volume 19
- Issue 4
Analgesic use may decrease postmenopausal estrogen levels
Postmenopausal women who regularly use painkillers have lower estrogen levels, which could lead to a decreased risk of breast or ovarian cancer.
Postmenopausal women who regularly use painkillers have lower estrogen levels, which could lead to a decreased risk of breast or ovarian cancer, according to researchers at Boston's Brigham and Women's Hospital and Harvard Medical School (Cancer Epidemiol Biomarkers Prev online, March 23, 2010).
The investigators looked at the link between the use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen and concentrations of estrogens and androgens among 740 postmenopausal women who participated in the Nurses' Health Study. The frequency of all analgesic use was inversely associated with estradiol, free estradiol, estrone sulfate, and the ratio of estradiol to testosterone. The average estradiol levels were 10.5% lower among women who regularly used aspirin or non-aspirin NSAIDs. Free estradiol levels were 10.6% lower and estrone sulfate levels were 11.1% lower among regular users of aspirin.
Articles in this issue
over 15 years ago
Thyroid Cancer: Shifts in Surgical Management and Follow-upover 15 years ago
High dietary polyamines may foster colorectal adenomasover 15 years ago
Duke doctor named new chair of NCCN board of directorsover 15 years ago
Study sheds light on lung cancer and African Americansover 15 years ago
Everolimus achieves ‘potent’ results in rare form of NHLover 15 years ago
Who's Newsover 15 years ago
Healthcare legislation boosts future of cancer care servicesover 15 years ago
Complete resection of kidney mets ups overall survivalNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































